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Abstract (121 words) 
Aneuploidy, a condition characterized by chromosome gains and losses, causes reduced fitness 
and numerous cellular stresses, including increased protein aggregation. Here, we identify 
protein complex stoichiometry imbalances as a major cause of protein aggregation in aneuploid 
cells. Subunits of protein complexes encoded on excess chromosomes aggregate in aneuploid 5 
cells, which is suppressed when expression of other subunits is coordinately altered. We further 
show that excess subunits are either degraded or aggregate and that protein aggregation is nearly 
as effective as protein degradation at lowering levels of excess proteins. Our study explains why 
proteotoxic stress is a universal feature of the aneuploid state and reveals protein aggregation as 
a form of dosage compensation to cope with disproportionate expression of protein complex 10 
subunits. 
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Introduction 
Eukaryotes have a problem - subunits of protein complexes are not encoded in operons. 
Although eukaryotes have evolved to coordinate expression of subunits of the same complex (Li 
et al. 2014; Taggart and Li 2018), changes in gene dosage of a subset of subunits of a protein 
complex, transient gene copy number imbalances during DNA replication, or fluctuations in 5 
gene expression can disrupt this coordinate expression, leading to the production of complex 
subunits that lack their binding partners. These orphan subunits have the potential to mis-fold 
and cause proteotoxic stress. How eukaryotic cells deal with stoichiometric imbalances is a 
fundamental, yet largely unexplored question.  
 10 
Aneuploidy represents an especially dramatic case of gene dosage alteration because changes in 
autosome copy number generally lead to a corresponding change in the levels of RNAs and 
proteins produced by genes located on aneuploid chromosomes (Torres et al. 2010; Pavelka et al. 
2010; Dephoure et al. 2014). Not surprisingly these dramatic alterations in cellular protein 
composition significantly impact cellular physiology, causing cell proliferation defects, 15 
metabolic alterations, and oxidative stress (reviewed in (Santaguida and Amon 2015)). Protein 
homeostasis defects are especially prevalent in aneuploid cells. In budding yeast, many different 
aneuploidies harbor more protein aggregates, display decreased chaperone activity, and exhibit 
sensitivity to conditions that interfere with proteasomal degradation (Oromendia et al. 2012; 
Torres et al. 2007). In mammals, aneuploidy also disrupts protein homeostasis leading to altered 20 
autophagy, abnormal protein folding, and accumulation of protein aggregates (Donnelly and 
Storchová 2014; Santaguida et al. 2015; Stingele et al. 2012; Tang et al. 2011). Why protein 
aggregation is so wide-spread in aneuploid cell lines was not understood. 
 
We previously generated a series of haploid yeast strains each harboring an extra copy of one of 25 
the 16 yeast chromosomes (henceforth disomes; (Torres et al. 2007)). Analysis of the 
localization of Hsp104, a disaggregase that associates with protein aggregates (Liu et al. 2010), 
showed that gain of any of the 16 yeast chromosomes causes an increase in the number of cells 
harboring Hsp104 foci, providing evidence for increased protein aggregation (Oromendia et al. 
2012). Here we determine the molecular basis of this phenotype. We find that subunits of protein 30 
complexes encoded on excess chromosomes aggregate in aneuploid cells. Our analyses also 
provide insights into how cells respond to protein stoichiometry imbalances. Protein aggregation 
can quantitatively deplete excess protein from the cytosol. We conclude that protein aggregation 
commonly performs functional dosage compensation. 
 35 
RESULTS 
Identification of proteins that aggregate in aneuploid yeast cells 
Previous studies of proteotoxic stress in aneuploidy had shown that cells with defined 
chromosome gains or randomly generated, unknown karyotypes harbored increased levels of 
protein aggregates (Oromendia et al. 2012; Santaguida et al. 2015; Stingele et al. 2012). To gain 40 
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insight into why protein aggregation is so common in aneuploid cells, we determined the 
composition of protein aggregates in disomic yeast strains. We isolated protein aggregates from 
disomic yeasts strains by a stringent differential centrifugation method (Koplin et al. 2010). 
Hsp104 was enriched in aggregate fractions (Fig. 1A), however we note that aggregates isolated 
in this manner may not contain all Hsp104 decorated aggregates, and also may contain 5 
aggregates not recognized by Hsp104. Analysis of protein aggregates by SDS-PAGE revealed 
that protein aggregation is increased in aneuploid cells. Cells that mis-segregate chromosomes at 
a high frequency because they carry a temperature sensitive allele in the kinetochore component 
encoding gene NDC10 harbored high levels of protein aggregates (Fig. 1B). Increased amounts 
of aggregated proteins were also observed in haploid cells disomic for chromosome V (Fig. 1B).  10 
 
Having established that aneuploidy causes an increase in protein aggregates that can be isolated 
by differential centrifugation, we used SILAC mass spectrometry (ms) to identify proteins that 
preferentially aggregate in 12 different disomic yeast strains (Ong et al. 2002; Shevchenko et al. 
2006) (Supplemental Fig. S1A; Fig. 1C; Supplemental Data S1). Reproducibility was high 15 
between individual experiments: 70% of proteins were identified in repeats of individual 
experiments (Supplemental Fig. S1B, C). Although biological replicates were well correlated, 
the mean of the SILAC ratios for all proteins combined in aggregates varied between replicates 
of the same disome (e.g. for disome II, the means were 0.59, 0.69, and 0.30). To account for this 
variability and to be able to conduct analyses on the aggregate data set as a whole, we mean 20 
centered all experiments such that the mean relative enrichment was equal across experiments 
(Fig. 1C). Each experiment was mean-centered to 0 by subtracting the mean of all SILAC ratios 
in that experiment from all data points. To return the normalized values to a baseline that more 
closely resembles the increase in protein aggregation in disomic strains observed in the raw data, 
a constant (log2 0.27) was added to all normalized data points. This constant is the mean log2 25 
ratio of all euploid encoded proteins in the dataset prior to normalization. Of note, we also 
identified proteins that were enriched in aggregates isolated from euploid strains compared to 
disome strains. However, in triplicate experiments for disome II, only 4 proteins (1.4%) were 
enriched more than two-fold in aggregates from euploid cells and their enrichment across 
replicate experiments was highly variable (Supplemental Fig. S1D, E).   30 
 
Which proteins aggregate in disomic yeast strains? The similar banding patterns of WT and 
aneuploid aggregates on SDS-PAGE gels (Fig. 1B) indicated that aggregates were composed of 
the same proteins, but that they aggregate more in aneuploid strains than euploid strains. 
Comparison of the banding pattern of protein aggregates on SDS-PAGE with the banding pattern 35 
of purified ribosomes further suggested that protein aggregates of both euploid and disomic yeast 
strains were enriched for ribosomes (Supplemental Fig. S2A). To estimate the contribution of 
ribosomes to protein aggregates in disomic yeast strains we first determined the abundance of 
proteins in aggregates in each strain relative to its euploid reference by summing the raw total 
intensity of all heavy-labeled peptides and all light-labeled peptides and then calculating a ratio 40 
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of the two (Supplemental Fig. S2B). Nine out twelve disomic strains contained more aggregated 
protein than euploid controls by this estimate. We then calculated the signal of each ribosomal 
protein as a percentage of the total signal for all aggregated proteins and determined that 75% of 
aggregated proteins were ribosomal proteins. Interestingly, the disomic strains with fewer 
ribosomes aggregating were the same strains that showed lower levels of total aggregate burden 5 
(compare Supplemental Fig. S2B and C) confirming that ribosomes make up the majority of 
aggregating proteins in disomic yeast strains. Two lines of evidence indicate that it is assembled 
ribosomes rather than individual subunits that accumulate in aggregates. First, almost all excess 
ribosomal subunits are quantitatively degraded in disomic yeast strains (Dephoure et al. 2014). 
Second, the coomassie staining pattern of protein aggregates on SDS-PAGE resembles the 10 
pattern of purified intact ribosomes (Supplemental Fig. S2A). We conclude that ribosomes are 
abundant in aggregates purified by our method in both euploid and aneuploid yeast strains, but 
that they aggregate more in disomes. 
 
To determine which proteins other than ribosomes are found in aggregates purified by our 15 
differential centrifugation method, we assessed the presence of known phase-separated structures 
such as P bodies, stress granules, or nucleoli in purified aggregates (Banani et al. 2017) using the 
annotations by (Jain et al. 2016). P body proteins were significantly underrepresented in 
aggregates compared to total lysates (Supplemental Fig. S2D). We also identified fewer stress 
granule proteins and nucleolar proteins in aggregates compared to total lysates, however this 20 
difference was not significant (Supplemental Fig. S2D). We conclude that components of phase-
separated structures are not significantly enriched in our aggregate preparations. 
 
Next, we conducted an unbiased Gene Ontology (GO) analysis (Supplemental Fig. S2E) to 
determine which proteins were in fact enriched in aggregates isolated from aneuploid strains. 25 
Macromolecular complex was the GO term most significantly associated with proteins in 
aggregates, suggesting that complex subunits may be predisposed to aggregation. Ribosomes 
were the second most significant GO term, confirming our observation that the organelle is 
enriched in our aggregate preparation. The term “non-membrane bound organelle” (fourth most 
significant GO term) includes ribosomes which likely drives the significance of this GO term. 30 
The third most significant GO term was “cell”, which we interpret to mean that all GO terms 
with p-values larger than this generic GO term, which includes the GO terms mitochondrion, 
nucleolus, and membrane, are not likely to be meaningful. This conclusion is supported by our 
observation that proteins known to be components of the nucleolus are not enriched in 
aggregates isolated from disomic yeast strains.  35 
 
Next, we examined the physical and chemical properties of aggregating proteins. For this 
analysis, we compared aggregating proteins to the whole yeast proteome and to proteins 
identified in lysates from which the aggregates were purified. Proteins in both aggregates and 
total lysates had more disordered regions than the whole proteome (Supplemental Fig. S3A). 40 
Brennan et al.  
6 
 
6 
Hydrophobicity did not affect aggregation propensity (Supplemental Fig. S3B). Amino acid 
composition appeared to affect protein aggregation in aneuploid yeast strains. Aggregated 
proteins were more basic and contained slightly more aromatic residues than proteins identified 
in lysates (Supplemental Fig. S3C-E). Whether these features influence aggregation propensity 
remains to be determined. Based on our knowledge of the effects of aneuploidy on cell 5 
physiology and the fact that “macromolecular complex” was the most significant GO term 
describing proteins that aggregate in disomic yeast strains, we can, however, envision two 
classes of proteins that aggregate in disomic yeast strains:  
(1) Proteins that rely extensively on protein folding pathways to achieve their native 
conformation. Such proteins could aggregate because protein quality control is 10 
compromised in aneuploid yeast strains (Oromendia et al. 2012; Torres et al. 2010). 
Aggregation of these proteins ought to be independent of the identity of the aneuploid 
chromosomes and should occur in multiple different disomic yeast strains.  
 
(2) Proteins encoded by the duplicated chromosome. Such proteins could aggregate 15 
because they are in excess. 
 
We first focused on proteins in class 1. 
 
Proteins that aggregate in multiple disomes also aggregate in cells with compromised 20 
protein quality control  
Aneuploid cells experience proteotoxic stress (Oromendia et al. 2012; Santaguida et al. 2015; 
Stingele et al. 2012; Tang et al. 2011). Proteins that rely extensively on protein folding pathways 
to achieve their native conformation could thus aggregate in aneuploid cells more so than in 
euploid cells. To identify proteins that exhibit an increased aggregation due to the aneuploid 25 
state, we identified proteins that (1) were encoded on euploid chromosomes, (2) aggregated in at 
least 3 different disomic yeast strains, and (3) had an average enrichment of at least 2.4-fold 
[log2 1.27] in disomic aggregates. We arrived at this cutoff for enrichment of proteins in disome 
aggregates using a false discovery rate of 5% (see Materials and Methods). This analysis 
identified 22 proteins (Fig. 1D; Supplemental Data S2). 30 
 
If proteins aggregate in multiple different disomic strains because proteostasis is compromised 
they should also aggregate in euploid cells in which protein quality control pathways are 
inhibited. To test this, we analyzed protein aggregates of cells harboring a temperature sensitive 
mutation in the proteasome subunit encoding gene RPN6 (Isono et al. 2005) and of cells treated 35 
with the Hsp90 inhibitor radicicol (Supplemental Fig. S4; Supplemental Data S2). For the 22 
proteins identified as aggregating in multiple disomic strains, we obtained quantitative 
information for 14 in aggregates of either rpn6-1 or radicicol-treated cells, or both. Of these, 13 
(94%) were enriched 2.4-fold [log2 1.27] in aggregates of rpn6-1 or radicicol-treated cells, or 
both (Fig. 1E, p<0.001, hypergeometric cumulative distribution function). We conclude that 40 
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proteostasis deficiency causes protein aggregation in aneuploid cells regardless of whether gene 
copy number is altered or not.  
 
Duplicated proteins are highly enriched in aneuploid aggregates  
We next examined proteins encoded on disomic chromosomes. These proteins were indeed 5 
significantly enriched in aggregates isolated from their respective disomic strain (Fig. 1C; red 
dots). To determine the number of proteins that aggregate because they are produced from two 
rather than one gene copy, we used a cutoff of 2.4-fold [log2 1.27] (based on a 5% FDR, 
described above) to define aggregate enrichment. We identified 437 proteins that were enriched 
in aggregates in a disome-specific manner (Supplemental Data S1; Fig. 1F). For example, 10 
chromosome II encodes for 13% of the yeast proteome when duplicated, yet 36% of proteins that 
aggregate in strains disomic for chromosome II are encoded on chromosome II. Similarly 
dramatic results are observed in all disomic strains (Fig. 1F). We further note that this 
enrichment of disome-encoded proteins in aggregates underestimates proteins that aggregate 
because they are produced in excess. Proteins that fall below an established signal to noise ratio 15 
in either the heavy or light channel cannot be included because a SILAC ratio cannot be 
calculated. To mitigate this limitation, we examined proteins that did not pass the signal to noise 
threshold in one channel, but had a signal to noise ratio (S:N) of at least twice the threshold in 
the other channel (see Materials and Methods). This identified an additional 320 proteins that 
were quantified only in disome aggregates compared to just 72 that were only identified in 20 
aggregates of the euploid control strain (Supplemental Data S1). Importantly, 92 of the proteins 
quantified only in aggregates of disomic strains were encoded on the disomic chromosome, as 
opposed to just 2 that were quantified only in aggregates of euploid strains (Fig. 1G). We 
conclude that at least 529 proteins (437 proteins identified as enriched in disomes compared to 
wild-type aggregates + 92 identified only in disome aggregates) aggregate when their gene copy 25 
number is increased by two-fold. 
 
Increasing gene copy number by one causes protein aggregation in human cells 
Is protein aggregation a feature of aneuploidy that is conserved across eukaryotes? To address 
this question, we analyzed protein aggregation in near diploid human RPE-1 cells and two 30 
derivatives that were trisomic for chromosomes 12 or 21 (Stingele et al. 2012). As in yeast, 
proteins most enriched in aggregates were encoded on the trisomic chromosome. Within the 10th 
percentile of proteins most enriched in trisomy 12 aggregates, 16.2% of proteins were encoded 
by chromosome 12 (Fig. 2A, B; Supplemental Data S3). This enrichment was highly significant 
(Fisher’s exact test p<0.0001). In contrast, proteins encoded by other chromosomes had no 35 
significant enrichment, with the exception of proteins encoded by chromosome 4 which were 
slightly depleted (Fisher’s exact test p=0.0297). We conclude that chromosome 12-encoded 
proteins are enriched in aggregates of trisomy 12 cells.  
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Enrichment of chromosome 21-encoded proteins was not evident in aggregates purified from 
trisomy 21 cell lines (Fig. 2A, C; Supplemental Data S3) most likely due to the fact that 
chromosome 21 is the gene poorest chromosome in humans. To increase protein aggregation in 
trisomy 21 cells, we prevented protein degradation by inhibiting the proteasome and lysosomal 
degradation with MG-132 and chloroquine, respectively. In this experiment, we observed that 5 
within the 10th percentile of proteins most enriched in trisomy 21 aggregates, 3.2% were encoded 
by chromosome 21. Overall, proteins encoded on chromosome 21 represent only 1% of proteins 
in aggregates (Fig. 2D, E; Supplemental Data S3). This enrichment was highly significant 
(Fisher’s exact test p=0.0005). In contrast, proteins encoded on other chromosomes did not show 
significant enrichment. Among the chromosome 21 encoded proteins enriched in aggregates 10 
were two proteins known to contribute to disease phenotypes in Trisomy 21 - DOPEY2, a 
protein implicated in causing mental retardation (Rachidi et al. 2005) and APP, the precursor of 
the Alzheimer’s disease-associated amyloid-β. We conclude that aggregation of proteins encoded 
on excess chromosomes is also a feature of aneuploidy in humans. We note that the enrichment 
of proteins encoded on excess chromosomes is less apparent in trisomic human cells than in 15 
disomic yeast cells. This is to be expected. Gain of a copy of a chromosome in a diploid cell 
causes fewer protein imbalances than gain of a chromosome in a haploid cell.  
 
Stoichiometric imbalance of protein complexes can cause protein aggregation 
We next examined the mechanism whereby altering gene copy number causes protein 20 
aggregation in aneuploid cells. Protein complex analysis using the annotation by (Pu et al. 2009) 
showed that 44.2% of the 529 proteins, that aggregated in disomic yeast strains when encoded on 
an excess chromosome, were subunits of protein complexes (Fig. 3A). By comparison, only 
29.2% of proteins encoded by euploid chromosomes that were enriched in aggregates, were 
subunits of protein complexes (Fig. 3A).  25 
 
We hypothesized that the enrichment of duplicated protein complex subunits in disome 
aggregates was due to protein complex subunits requiring binding to other subunits to acquire 
their native state. This hypothesis predicts that when gene copy number of the other complex 
subunits is altered in accordance with expression of the subunit produced in excess, aggregation 30 
should be prevented. We tested this prediction by studying the eIF2 complex, which is required 
for translation initiation and composed of three subunits. The eIF2 γ-subunit, Gcd11, is encoded 
on chromosome V (Fig. 3B). Gcd11 was found in aggregates isolated from yeast strains disomic 
for this chromosome but returned to euploid levels in aggregates from disome V strains in which 
one copy of GCD11 was deleted (Fig. 3C-E). In fact, a single extra copy of GCD11 in an 35 
otherwise euploid strain was sufficient to cause Gcd11 aggregation (Fig. 3C-E). Thus, increased 
gene dosage of GCD11 is necessary and sufficient to cause aggregation of the protein. It is worth 
noting that Gcd11 aggregated less when expressed in excess by itself than when overexpressed 
due to an extra copy of chromosome V. This observation suggests that proteotoxic stress caused 
by disomy of chromosome V exaggerates aggregation of Gcd11. 40 
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To test whether aggregation of Gcd11 in disome V strains can be prevented by doubling the gene 
copy number of the eIF2 α-subunit encoding gene SUI2 and the eIF2 β-subunit encoding gene 
SUI3, we introduced a centromeric plasmid carrying both genes under their native promoters into 
disome V strains. Expression of SUI2 and SUI3 dramatically reduced Gcd11 aggregation in 5 
disome V cells (Fig. 3F-H). We note that expression of SUI2 and SUI3 also increased Gcd11 
levels in lysates (Fig. 3F). A pool of Gcd11 is degraded when expressed in excess (Dephoure et 
al. 2014). Increased expression of Sui2 and Sui3 likely also protects Gcd11 from degradation. 
We conclude that stoichiometric imbalance of protein complexes can cause protein aggregation 
in aneuploid cells. 10 
 
Excess proteins either aggregate or are degraded 
Previous studies showed that many proteins that function in protein complexes are degraded 
when in excess in aneuploid cells, restoring their levels to euploid or near euploid levels 
(Dephoure et al. 2014; Gonçalves et al. 2017; Ori et al. 2016). We observed that many proteins 15 
aggregate when in excess. An important question regarding these two observations is whether 
excess subunits are down-regulated by both mechanisms or whether they are neutralized by one 
or the other. To distinguish between these possibilities, we analyzed protein degradation and 
aggregation propensity for all disome-encoded proteins identified in our protein aggregate 
analysis and the protein degradation analysis of Dephoure et al. (2014). Note that both data sets 20 
were created with the same strains. Analysis of the relative abundance of proteins encoded on 
disomic chromosomes confirmed that the two data sets were indeed similar to each other, despite 
slight differences in growth conditions (Supplemental Fig. S5). 
 
We first asked whether relative abundance of a protein in total lysates correlates with protein 25 
aggregation - or in other words, is a protein more likely to aggregate when its levels in total 
lysate are higher than in a euploid strain? We indeed observed a weak but significant correlation 
(Fig. 4A). This observation indicates that proteins that are dosage compensated by protein 
degradation are less likely to be found in aggregates. Because excess cytoplasmic ribosomal 
subunits are almost exclusively degraded (Dephoure et al. 2014), we also asked whether the 30 
correlation was driven by ribosomal proteins. Removing cytoplasmic ribosomal proteins from 
the data set weakened the correlation between abundance of proteins in extracts and their 
propensity to aggregate, but it was still significant (Supplemental Fig. S6A). 
 
To further assess whether protein aggregation and degradation are mutually exclusive we 35 
analyzed the data using cutoffs previously set to define a protein to aggregate or to be degraded 
when in excess. Dephoure et al. (2014) defined a disome-encoded protein as degraded when its 
abundance in extracts relative to a euploid reference was 1.52 [log2 0.6] instead of the expected 
2 [log2 1]. We defined any disome-encoded protein aggregated when it was found enriched 2.4-
fold [log2 1.27] in aggregates (Fig. 1). Based on these criteria, only 100/983 (10%) disomic 40 
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proteins were considered both to aggregate and to be degraded when in excess. This is evident by 
the fact that the upper left quadrant in the graph in Fig. 4A is underpopulated (p= 0.0045; 
Fisher’s exact test). This mutual exclusive behavior of disome encoded proteins was not driven 
by ribosomal proteins because we observed the same under population of the left upper quadrant 
when we removed ribosomal proteins (Supplemental Fig. S6A). When we restricted our analysis 5 
to subunits of protein complexes only 67 out of 424 (16%) proteins were both enriched in disome 
aggregates and degraded when in excess (p= 0.0012; Fisher’s exact test; Fig. 4B), although we 
note that this observed lack of overlap between aggregation and degradation was, to a significant 
extent, driven by ribosomal proteins (Supplemental Fig. S6B).  
 10 
Another way to assess whether disome-encoded proteins aggregate or are degraded but not both, 
is to ask: Are disome-encoded proteins that are highly enriched in aggregates, present in total 
lysates at the 2x level expected for disome-encoded proteins or are their levels lower? We found 
that disome-encoded proteins that are enriched in aggregates, are present at levels close to the 
expected level of two-fold indicating that they are not degraded (Fig. 4C). In contrast, levels of 15 
proteins that were detected in aggregates but not enriched in aggregates were lower in total 
lysates (Fig. 4C). Removal of ribosomal subunits from the analysis did not alter this conclusion 
(Supplemental Fig. S6C). The results were even more striking when we focused our analysis on 
disome-encoded proteins that are part of protein complexes (Fig. 4D, S3D). We conclude that 
proteins, when present in excess, have a preferred fate of either degradation or aggregation. 20 
 
Protein complex subunits that aggregate when in excess have lower turnover rates than 
degraded subunits 
What determines whether excess protein complex subunits aggregate or are degraded? 
Computational analyses revealed that both classes of subunits harbor large protein-protein 25 
interfaces within their complexes compared to proteins that neither aggregate nor are degraded 
(Fig. 5A; Supplemental Data S4; (Marsh et al. 2013)). This is consistent with earlier work in 
mammalian cells, demonstrating that protein complex subunits with larger interfaces tend to be 
unstable and rapidly degraded when not bound to their partners (McShane et al. 2016). If 
overexpressed relative to other components of the complex, these large interfaces could facilitate 30 
inappropriate protein-protein interactions, leading to aggregation instead of degradation (Levy et 
al. 2012). 
 
Given that excess protein complex subunits that are degraded and that aggregate both harbor 
large protein binding interfaces, we hypothesized that their fate could be determined by 35 
differences in recognition by the ubiquitin/proteasome or lysosomal degradation systems. 
Previous work showed that degradation of proteins that are encoded on a disomic chromosome, 
can be prevented by treating disomic cells with the proteasome inhibitor MG-132 and the 
lysosomal-degradation inhibitor chloroquine ((Dephoure et al. 2014), Fig. 5B; right part of the 
graph). Importantly, we find that preventing protein degradation did not affect overall levels of 40 
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individual proteins that aggregate (Fig. 5B, left part of the graph) and average levels of all 
proteins that aggregate (Fig. 5C; Supplemental Data S4). Therefore, proteins found in aggregates 
generally have low turnover rates. 
 
To further assess whether protein stability determines whether or not a protein aggregates, we 5 
analyzed the effects of proteasome inhibition on the fate of proteins that are normally degraded 
when in excess. Partial inhibition of the proteasome using a temperature sensitive rpn6-1 mutant 
grown at the semi-permissive temperature (30°C) caused a general increase in protein 
aggregation for all proteins in disome II cells (Fig. 5D; Supplemental Data S4). 67 disomic 
proteins are normally degraded in cells disomic for chromosome II (Dephoure et al. 2014). We 10 
identified 31 of these in our analysis. 11 out of 31 (35.5%) aggregated in disome II cells with a 
functional proteasome. In disome II rpn6-1 cells we identified 41 out of these 67 proteins. 21 
(51.2%) of these were enriched in aggregates (Fig. 5E). We then asked whether the 67 proteins 
that were typically degraded when duplicated in disome II cells were enriched in aggregates 
when proteasome function is compromised. In cells with normal proteasome function, the 67 15 
proteins had a mean enrichment of 1.9 [log2 0.92] in disome II aggregates. In disome II rpn6-1 
cells, their mean enrichment increased to 4.0 [log2 2.0] indicating that many of these usually 
degraded proteins are now deposited in protein aggregates (Fig. 5F). 
 
We next determined the effects of protein stability on the choice between degradation or 20 
aggregation by analyzing the origin recognition complex (ORC) in which some subunits are 
degraded when in excess while others are not (Dephoure et al. 2014). The origin recognition 
complex (ORC) is a six subunit complex essential for the initiation of DNA replication (Bell et 
al. 1993). All six subunits are encoded on different chromosomes in yeast.  
 25 
Orc2 levels are mostly attenuated (reduced to 1.1 [log2 0.16] relative to WT) by degradation 
when the ORC2 gene is present in two copies instead of one ((Dephoure et al. 2014), Fig. 5G). In 
contrast, Orc5 is not attenuated (present at 1.8 [log2 0.88] relative to WT) by degradation but is 
highly enriched in aggregates when encoded by two gene copies (Fig. 5G, H). To mimic 
stoichiometric imbalance, we transiently overexpressed Orc2 and Orc5 individually from the 30 
galactose-inducible GAL1-10 promoter. Half-life measurements showed that overproduced Orc5 
was twice as stable as overproduced Orc2 (Fig. 5I, J). We conclude that the stability of a protein 
can determine whether it aggregates or is degraded when produced in excess. Our data further 
indicate that surprisingly subtle half-life differences can determine a protein’s dosage 
compensation fate. What minimal half-life is required for a protein to be eliminated by 35 
degradation when in excess remains to be determined. 
 
Dosage compensation by protein aggregation 
Degradation of excess subunits of protein complexes serves as a form of dosage compensation 
(Dephoure et al. 2014). Can protein aggregation serve the same purpose by sequestering excess 40 
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subunits in an inaccessible aggregate compartment? To address this question, we quantified the 
relative abundance of proteins that remained in the soluble fraction following aggregate isolation 
in yeast strains disomic for chromosome II or XII and compared it to their abundance in extracts 
prior to aggregate removal (henceforth total lysate) (Supplemental Fig. S1A). We observed a 
small but nevertheless significant difference in relative abundance of proteins encoded on 5 
euploid chromosomes between soluble fractions and total lysates (Fig. 6A, B; Supplemental Data 
S5), which is consistent with the observation that proteins encoded on euploid chromosomes are 
also found enriched in aggregates isolated from aneuploid cells (Fig. 1C). Depletion of proteins 
encoded on disomic chromosomes from the soluble fraction was, however, much more dramatic. 
Their mean relative abundance in the soluble fraction was noticeably decreased to 1.59-fold 10 
[log2 0.67] compared to 1.66-fold [log2 0.74] in total lysates for disome II and 1.69-fold [log2 
0.76] compared to 1.77-fold [log2 0.82] for disome XII (Fig. 6A, B; Supplemental Data S5). 
 
The decrease of disome-encoded proteins in the soluble fraction could be due to many proteins 
experiencing small amounts of aggregation or a few proteins aggregating to a large degree. To 15 
distinguish between these possibilities, we first calculated the change in levels for each protein 
by subtracting protein levels in the soluble fraction from those in the total lysate. We then pooled 
the data from the disome II and disome XII analysis and generated two bins – proteins that were 
encoded on disomic chromosomes and proteins encoded on euploid chromosomes. As expected, 
the changes in levels of the 6495 proteins encoded by euploid chromosomes were evenly 20 
distributed (Fig. 6C; gray bars); changes in levels of the 575 proteins encoded by disomic 
chromosomes were not. Both the mean and skew significantly deviated from the expected 
distribution (Fig. 6C). 147 of the 575 (26%) disome-encoded proteins were depleted by 1.15-fold 
[log2 0.2] in the soluble fraction compared to total lysate (Fig. 6E), 12% by 1.32-fold [log2 0.4]. 
Full attenuation, as defined as a 1.74-fold [log2 0.8] decrease occurred for 3% of proteins (Fig. 25 
6E). This indicates that reduction in protein levels for duplicated proteins in the soluble fraction 
is largely due to many proteins decreasing by a small degree. However, full attenuation by 
aggregation also occurs. 
 
How does dosage compensation by aggregation compare to dosage compensation by protein 30 
degradation? Previous studies showed that 21% of proteins decrease by 1.52-fold [log2 0.6] 
either due to downregulation of gene expression or protein degradation (Dephoure et al. 2014). 
To assess what fraction of the proteome is attenuated solely by protein degradation we subtracted 
protein levels from RNA levels in the data set published by Dephoure et al. (2014). We then 
pooled data for disome II and disome XII, allowing us to examine 7328 measurements for 35 
proteins encoded on euploid chromosomes and 629 measurements for disome II and XII-encoded 
proteins. As expected, the changes in levels of the 7328 proteins encoded by euploid 
chromosomes were evenly distributed (Fig. 6D, gray bars). The 629 proteins encoded by disomic 
chromosomes behaved differently. Both the mean and skew were larger than observed in the 
expected distribution (Fig. 6D). 209 of the 629 (33.2%) disome-encoded proteins were depleted 40 
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by 1.15-fold [log2 0.2] relative to RNA levels (Fig. 6E); 18.4% by 1.32-fold [log2 0.4]. Full 
attenuation, (1.74-fold [log2 0.8]) occurred for 6.4% of proteins (Fig. 6E). We conclude that 
small degrees of attenuation of disome-encoded proteins occurs by both aggregation and 
degradation. Reduction to levels approaching those seen in euploid cells occurs predominantly 
through protein degradation. 5 
 
Finally, we asked whether dosage compensation of a particular protein was mediated by both 
protein degradation and aggregation, or one or the other in our disome II and XII data set. First, 
we determined whether a correlation existed between relative abundance of a disome-encoded 
protein in the total lysate and degree of dosage compensation by aggregation. This was the case, 10 
indicating that proteins with higher relative expression levels are more likely to be dosage 
compensated by aggregation (Fig. 6F). To further assess whether protein aggregation and 
degradation are mutually exclusive we analyzed the data using cutoffs previously defined 
(Dephoure et al. 2014). Disome-encoded proteins present in the total lysate at levels below 1.52 
[log2 0.6] (instead of the expected 2 [log2 1]) were considered dosage compensated by 15 
degradation. Disome-encoded proteins that were depleted in the soluble fraction by at least 1.52 
[log2 0.6] compared to the total lysate were considered dosage compensated by aggregation. 
Based on these criteria, only 9 out of 575 (1.6%) disomic proteins were dosage compensated by 
both aggregation and degradation, as evident by the fact that the upper left quadrant in the graph 
in Fig. 6F is underpopulated (p= 0.0011; Fisher’s exact test). We also asked whether disome-20 
encoded proteins that are dosage compensated by aggregation are present in total lysates at the 
2x level expected for disome-encoded proteins. This was the case (Fig. 6G), demonstrating that 
they are not degraded. In contrast, levels of proteins considered not dosage compensated by 
aggregation were lower in total extracts. Our data indicate that excess proteins are dosage 
compensated by aggregation or degradation but rarely both. 25 
 
Discussion 
Our analysis of protein aggregation in disomic yeast strains provided insight into why protein 
aggregation is a universal feature of the aneuploid state and revealed protein aggregation as a 
means of dosage compensation. This dosage compensation is not only relevant in aneuploid cells 30 
but could very well contribute to stoichiometry control in euploid cells that encounter 
stoichiometric imbalances due to transient imbalances caused by variability in gene expression. 
Remarkably, aggregation is nearly as effective as protein degradation at lowering levels of 
excess proteins. Whether protein aggregation serves a cytoprotective role in situations where 
high levels of unassembled complex subunits are present in cells (i.e. in aneuploid cells) is an 35 
important question that remains to be answered. 
 
Which proteins aggregate in aneuploid cells?  
Our analysis of protein aggregation in a series of disomic yeast strains provided insight into why 
protein aggregation is a universal feature of the aneuploid state. We identified proteins encoded 40 
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on the disomic chromosomes as well as proteins encoded on euploid chromosomes to be 
enriched in aggregates.  
 
Among the proteins found in aggregates of multiple different aneuploid strains, ribosomes were 
the most prominent. Ribosomes comprise ~75% of aggregates isolated from both euploid cells 5 
and aneuploid cells, but ribosomes aggregate more readily in aneuploid cells as judged by the 
fact that they harbor more aggregates. Why ribosomes are enriched in aggregates of disomic 
yeast strains is not clear. Perhaps a higher fraction of ribosomes is defective in disomic yeast 
strains causing them to aggregate.  
 10 
Ribosomes were not the only proteins commonly found in aggregates of aneuploid yeast strains. 
Interestingly, the proteins that aggregated in multiple different aneuploid cell lines also 
aggregated when protein quality control pathways were impaired. This observation raises the 
interesting possibility that proteins that are especially dependent on protein quality control 
pathways to maintain their solubility are “canary in the coal mine” proteins of the state of 15 
cellular protein quality control. It will be interesting to determine which properties make the 
canary proteins so sensitive to perturbations in protein homeostasis. 
 
We also analyzed proteins that aggregate because their encoding genes were duplicated due to 
disomy. These proteins were strongly enriched for subunits of protein complexes leading us to 20 
hypothesize that subunits of heteromeric protein complexes present at levels twice their binding 
partners are prone to aggregation. We went on to demonstrate that this was true in the case of the 
eIF2 complex. Our analysis of human trisomic cell lines further revealed that aggregation of 
proteins that are in excess is surprisingly sensitive to alterations in gene expression. Changing 
gene expression by as little as 50% causes aggregation of many proteins. 25 
 
Cellular response to excess subunits of protein complexes 
Our findings have important implications for euploid cells. Although expression of subunits of 
the same complex is tightly coordinated in eukaryotes (Li et al. 2014; Taggart and Li 2018), it is 
likely that even euploid cells encounter transient stoichiometric imbalances. Variability in 30 
expression of individual subunits can lead to stoichiometric imbalances where individual 
subunits lack binding partners or where protein complexes are only partially assembled.  
 
Our study shows that 61.5% of proteins either aggregate or are degraded when produced in 
excess. Among proteins that function in complexes, 73% of proteins either aggregate or are 35 
degraded. Interestingly, the 27% that are neither aggregated nor degraded have significantly 
smaller heteromeric protein binding interfaces than protein complex subunits that aggregate or 
are degraded. We propose that excess proteins that neither aggregate nor are degraded are simply 
less aggregation prone and lack the signals that target them for degradation. Whether there are 
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features that distinguish proteins that are degraded from proteins that are aggregated remains to 
be determined. 
 
Our data also indicate that aggregation and degradation of proteins encoded on disomic 
chromosomes is largely mutually exclusive. Intuitively this makes sense - if excess proteins are 5 
degraded there is no excess protein to aggregate. What determines whether excess proteins are 
degraded or aggregate is their half-life when unbound. This is what we observe for Orc2 and 
Orc5. Overexpressed Orc2 has a shorter overall half-life, presumably because excess Orc2 is 
degraded. Orc5 has a longer overall half-life when overexpressed because excess Orc5 
aggregates. What was surprising was that a change in protein half-life of two-fold appeared to 10 
determine whether an overexpressed protein aggregates or is eliminated by degradation. What 
determines the half-life of a protein and what minimal half-life is required to be eliminated by 
degradation when in excess remains to be determined.  
 
Dosage compensation by protein aggregation 15 
Our results indicate that protein aggregation is nearly as effective as protein degradation at 
lowering levels of excess proteins. Using stringent cutoffs to designate a protein being dosage 
compensated, we found that 12% of disome-encoded proteins were depleted from the soluble 
fraction by 1.32-fold due to aggregation; depletion by protein degradation occurred for 18.4% of 
proteins.  20 
 
We hypothesize that protein aggregation could serve a cytoprotective function that shields 
aneuploid and euploid cells from toxic activities of excess protein complex subunits. Testing this 
hypothesis requires the development of methods that prevent protein aggregation in aneuploid 
cells, a task that has proven difficult. Protein aggregation as a cytoprotective mechanism has 25 
been proposed during cellular and organismal aging (David et al. 2010; Walther et al. 2015), 
suggesting that it could also serve this function in aneuploid cells. However, it is worth noting 
that the aggregation that occurs during aging does not function to normalize stoichiometric 
imbalances but rather to protect cells from highly abundant proteins that exceed their solubility 
during aging. Protein aggregation has also been found to protect cells during stress by 30 
sequestering misfolded proteins and targeting them to specific subcellular compartments 
(Escusa-Toret et al. 2013; Miller et al. 2015). Aggregation of disease inducing proteins such as 
amyloid β, associated with Alzheimers Disease, has also been proposed to protect neurons from 
toxic oligomers (Caughey and Lansbury 2003). Our observation that widespread aggregation 
serves the purpose of protecting cells from gene dosage excess raises the intriguing possibility 35 
that aggregation may be one mechanism that allows cancer cells to tolerate aneuploidy. Analysis 
of the degree of protein aggregation in cancer cell lines that are highly aneuploid and thus 
experience large scale stoichiometric imbalances yet have high proliferative potential, could shed 
light on this question. 
 40 
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Materials and Methods 
 
Yeast strains, plasmids, and growth conditions 
All yeast strains are derivatives of W303 and are described in Table S1. Primers are listed 
in Table S2 and plasmids are listed in Table S3. Yeast strains were generated and manipulated as 5 
described previously (Guthrie and Fink 1991). Cells were grown at 30°C in YEP supplemented 
with 2% raffinose (YEP-R), 2% raffinose + 2% galactose (YEP- RG), or 2% glucose (YEP-D), 
or in synthetic complete medium supplemented 2% glucose (SC-D). For SILAC experiments, 
cells were grown overnight in SC-D medium containing 100 µg/mL of heavy (13C6 15N2 (K8), 
Cambridge Isotope Labs) or light (K4) (Sigma-Aldrich) L-lysine. Cells were then diluted to 10 
OD600=0.05 to 0.1 and grown to OD600=0.4 to 1.0 before harvesting lysates. Strains harboring 
temperature sensitive mutations in NDC10 or RPN6 were grown over night at room temperature, 
grown to exponential phase at room temperature before shifting to the semi-permissive 
temperature of 30°C. ndc10-1 strains were grown for 4 hours and rpn6-1 strains were grown for 
6 hours at 30°C before harvesting for aggregate purification. For radicicol treatments, cells 15 
harboring a deletion in the gene encoding the drug transporter Pdr5 were grown to exponential 
phase in SC medium at 30°C and radicicol (Cayman Chemical Company) or DMSO was added 
to the culture at a final concentration of 70 µM. Cells were grown in the presence of radicicol or 
DMSO for 30 minutes at 30°C before harvesting for aggregate purification. 
Disomes used in this study are derivatives of those published in Torres et al. (2007). 20 
Gene deletions, fusion proteins, and promoter swaps were generated using PCR-based methods 
(Longtine et al. 1998) in a wild-type W303 yeast strain. Disomes carrying gene manipulations 
were constructed by crosses. Karyotypes of key disomic strains were verified by whole genome 
sequencing. 
GCD11-HA and GCD11∆ were generated by PCR based methods (Longtine et al. 1998). 25 
GCD11-HA with its native promoter and terminator was cloned into p24 by Gibson cloning 
(Gibson et al. 2009) and integrated at ura3 by NcoI digestion. The pSUI2/SUI3 CEN plasmid 
was constructed by Gibson cloning (Gibson et al. 2009) SUI2 and SUI3 with their native 
promoters and terminators into p158. 
 30 
Cell culture and SILAC labeling of RPE-1 cells 
 RPE-1 wild type (control) cells were grown in heavy (K8) SILAC DMEM medium 
(DMEM with high glucose—minus glutamine, lysine and arginine, supplemented with 10% 
dialyzed FBS (Gibco), 50g/mL K8 lysine (Cambridge Isotope Labs), 85g/mL arginine 
(Sigma-Aldrich), and 2mM glutamine/1mM sodium pyruvate (Thermo Fisher). RPE-1 cells 35 
trisomic for chromosome 12 or 21 were grown in light (K0) SILAC DMEM (same formulation 
as above, with 50g/mL K0 lysine; Sigma-Aldrich). Cells were cultured for 8 generations prior 
to testing K8 labeling efficiency by mass spectrometry, then expanded for harvest at passage 10. 
Prior to harvest, cells were treated with 25M chloroquine for 16 hours, followed by addition of 
1M MG-132 (Calbiochem) for 6 hours to induce protein aggregation. Cells were harvested by 40 
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trypsinization, neutralized in SILAC DMEM, and washed with PBS; an equal number of heavy 
and light cells were mixed (wild type + Ts12; wild type + Ts21), treated with sodium azide, and 
snap frozen for aggregate purification. 
 
Aggregate purification and analysis 5 
 Aggregate purification was carried out based on methods published by Koplin et al., 
(2010), with some modifications to the cell lysis procedure. Cells were grown to exponential 
phase in SC medium under the conditions indicated above. Sodium azide was added to a final 
concentration of 50 mM in the cultures before pelleting cells. 10 OD600 units of cell pellets were 
washed with 50 mM sodium azide and snap frozen in liquid nitrogen. Frozen pellets were then 10 
resuspended in 1 mL of buffer containing 1M sorbitol, 100mM sodium citrate, 60mM EDTA, 
10mM DTT, pH 7.0 (SCED), 1mM PMSF, and 2x protease inhibitor tablets (Roche). Cells were 
pelleted then resuspended in 1 mL of SCED buffer containing 1 mg/mL 20T Zymolyase (MP 
Biomedicals) and rotated gently for 8 minutes at room temperature. Digested cells were pelleted 
by spinning at 250xg for 5 minutes at 4°C. Pellets were washed gently in ice-cold SCED buffer 15 
containing 1mM PMSF and 2x protease inhibitors. Cells were lysed by resuspending in 1.5 mL 
of ice-cold lysis buffer containing 20mM NaPi pH 6.8, 10mM DTT, 1mM EDTA, 0.1% Tween 
20 (Sigma-Aldrich), 1 mM PMSF, and 5x protease inhibitors and then sonicated for 8 pulses at 
output level 4, 50% duty cycle. Lysates were cleared by spinning for 2 minutes at 850xg at 4°C 
yielding the total lysate fraction. Protein concentrations of the cleared lysate were determined by 20 
Bradford (Bio-Rad). For quantitative Western blotting and Coomassie staining, samples were 
diluted to the same protein concentration. A small aliquot of the total lysate fraction was taken 
for analysis and aggregates were pelleted from the remainder of the total lysate by spinning the 
extract for 20 minutes at 16,000xg at 4°C. The supernatant was removed and reserved as the 
soluble fraction. Pellets were then washed twice by resuspending in buffer containing 20mM 25 
NaPi pH 6.8, 2% NP40, 1mM PMSF, and 2x protease inhibitors then sonicating for 6 pulses at 
output level 4, 50% duty cycle. A final wash was carried out in buffer containing 20mM NaPi 
pH 6.8, 1mM PMSF, and 2x protease inhibitors then sonicating for 4 pulses at output level 2, 
60% duty cycle yielding the aggregate fraction. All centrifugations during the wash steps were 
20 minutes at 16,000xg at 4°C. 30 
 For Western blot analysis and Coomassie staining analysis, total lysate fractions were 
boiled in SDS loading buffer. Aggregate fractions were resuspended in buffer containing 200mM 
NaPi pH 6.8, 5% SDS, 8M Urea, 10mM DTT, and 0.01% bromophenol blue (HU buffer) then 
vortexed at 1500 rpm for 5 minutes at 60°C. For coomassie staining, SDS-PAGE gels were 
stained with Imperial protein stain (Thermo Scientific) per manufactures instructions. For 35 
Western blotting, proteins were separated by SDS-PAGE then transferred to nitrocellulose 
membranes and detected by the following antibodies. Hsp104-eGFP was detected using a mouse 
anti-GFP antibody (JL-8 epitope, Clontech) at a dilution of 1:1000. Pgk1 was detected using a 
mouse anti-Pgk1 antibody (Invitrogen) at a 1:10,000 dilution. Gcd11-HA was detected using a 
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mouse anti-HA antibody (HA.11 epitope, BioLegend). Quantification was performed using Fiji 
software (Schindelin et al. 2012). 
 
Ribosome purification 
 Cells were grown to exponential phase, pelleted by centrifugation, washed with water, 5 
then snap frozen in liquid nitrogen. Cells were incubated in lysis buffer (20 mM HEPES pH 7.4, 
100mM potassium acetate, 2mM magnesium acetate, 3mM DTT, protease inhibitor tablets, and 1 
mg/mL Zymolyase) for 5 minutes at 4°C then lysed by French Press (Sim-Aminco). The lysate 
was cleared by centrifuging for 20 minutes at 19,000 RPM (Beckman Coulter JA25.50 rotor) at 
4°C. The cleared lysates were applied to a 30% sucrose gradient containing 20 mM HEPES pH 10 
7.4, 500mM potassium acetate, 2mM magnesium acetate, and 3mM DTT. Ribosomes were 
pelleted by centrifugation for 4 hours at 4°C at 50,000 RPM (Beckman Coulter Type 70 Ti 
rotor). The pellet was dissolved in lysis buffer and analyzed by SDS-PAGE. 
 
Quantitative Proteomics of Yeast Aggregates 15 
5 OD600 units of heavy-labeled cells were mixed with 5 OD600 units of light-labeled cells 
and aggregates were harvested as described above. Purified SILAC-labeled aggregates were 
boiled in SDS lysis buffer (50mM Tris pH 7.5, 2mM EDTA, 2% SDS) and separated on 4-12% 
Tris-Glycine by SDS-PAGE gels (Invitrogen). Proteins were visualized by Coomassie staining 
(45% methanol, 5% glacial acetic acid, 3g/L Coomassie brilliant blue G-250) and subjected to 20 
gel band cutting (Shevchenko et al. 2006), destaining, and in-gel Lys-C (Wako Chemicals) digest 
at a 50:1 protein to protease ratio to liberate peptides. Following digest, the buffer containing 
peptides and gel slices were acidified using 50% acetonitrile/5% formic acid, and recovered 
peptides were vacuum centrifuged to near dryness. Each gel fraction was desalted via StageTip, 
dried via vacuum centrifugation, and reconstituted in 5% acetonitrile, 5% formic acid for LC-25 
MS/MS processing. 
 
Quantitative proteomics of RPE-1 cell aggregates 
 RPE-1 cells were cultured and treated as described above. Aggregate purification was 
carried out as described for yeast cells with the following modifications. Cells were collected, 30 
treated with sodium azide and snap frozen. Frozen cell pellets were resuspended in cold lysis 
buffer (described above) and sonicated. Samples were analyzed using the same mass 
spectrometric method and data processing workflow as yeast aggregates (see below). 
 
Liquid chromatography and mass spectrometry 35 
MS data were collected using a Q Exactive mass spectrometer (Thermo Fisher) coupled 
with a Famos autosampler (LC Packings) and an Accela600 liquid chromatography (LC) pump 
(Thermo Fisher). Peptides were separated on an ~18cm column with 100µm inner diameter 
packed with of Accucore150 resin (2.6 μm, 150 Å, ThermoFisher Scientific, San Jose, CA); 
~1µg peptides were loaded onto the column for each analysis. Peptides were separated with a 40 
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2hour gradient of 5-26% acetonitrile in 0.125% formic acid with a flow rate of ~300nL/min. For 
the MS1 scan, resolution was set to 70,000 with an automatic gain control (AGC) target 1 × 106 
and a maximum injection time of 250 ms. We selected the top 20 precursors for HCD MS2 
analysis with the following parameters: resolution, 17,500; AGC 1 × 105; maximum injection 
time, 90 ms; isolation window, 2 Th; normalized collision energy (NCE), 25; and centroid 5 
spectrum data type. In addition, unassigned and singly charged species were excluded from MS2 
analysis, and dynamic exclusion was set to automatic. 
For data analysis, mass spectra were processed using a Sequest-based in-house software 
pipeline. MS spectra were converted to mzXML using a modified version of ReAdW.exe. MS2 
spectra were searched with a database including all predictive ORFs for entries from the yeast 10 
SGD (http://www.yeastgenome.org/download-data; downloaded March 12, 2014). For human 
aggregate samples, Database searching included all entries from the human UniProt database (10 
August 2011). Both yeast and human databases were concatenated with a reverse database 
composed of all protein sequences in reverse order. Searches were performed using a 50ppm 
precursor ion tolerance. Product ion tolerance was set to 0.03 Th. Oxidation of methionine 15 
residues (+15.995 Da) and heavy lysine (K8) incorporation (+8.0142) were set as a variable 
modification. Peptide spectral matches (PSMs) were altered to a 1% False discovery rate (FDR) 
(Elias and Gygi 2007; 2010). PSM filtering was performed using a linear discriminant analysis, 
as described previously (Huttlin et al. 2010), while considering the following parameters: XCorr, 
ΔCn, missed cleavages, peptide length, charge state, and precursor mass accuracy. Peptide-20 
spectral matches were identified, quantified, and collapsed to a 1% FDR and then further 
collapsed to a final protein-level FDR of 1%. Furthermore, protein assembly was guided by 
principles of parsimony to produce the smallest set of proteins necessary to account for all 
observed peptides. 4 gel band regions were cut per sample (individual lanes) of the SDS-PAGE 
gel; these 4 regions were processed separately and each is an independent MS sample (to 25 
decrease complexity of peptides in each run). Protein assembly was utilized to group the 4 runs 
of a given sample together for batched analysis and calculation of log2(Heavy/Light) ratios. The 
resulting data were filtered for SILAC quantified proteins based on the summed signal to noise 
for heavy and light peptides; contaminant peptides identified in the search were removed at this 
step. An intensity cutoff of 10 was applied for summed heavy plus light channels, and each 30 
individual channel had an intensity cutoff of 5 (to avoid identifying proteins with an intensity of 
0 in either the light or heavy channel; i.e. proteins found only in one condition or the other). A 
SILAC-labeled total lysate reference sample (to allow for normalization of SILAC mixing) was 
obtained as described above. Proteins were pelleted by TCA precipitation, dried via vacuum 
centrifugation, and digested with Lys-C. Resulting peptides were desalted using StageTips, and 35 
MS data collection and analysis were performed as described above for aggregate samples.  
 
SILAC mass spectrometry of total lysate and soluble fractions 
 Total lysate samples were prepared, and soluble fractions (supernatant post aggregate 
isolation) were collected as described above. ~800µg of protein per sample was pelleted via TCA 40 
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precipitation and dried via vacuum centrifugation. Samples were reduced and alkylated followed 
by digestion with Lys-C. Resulting peptides were desalted using StageTips and samples were 
dried via vacuum centrifugation.  
Each sample was fractionated using off-line basic pH reversed-phase chromatography 
(BPRP HPLC) (Wang et al. 2011). We used an Agilent 1200 pump equipped with a degasser and 5 
a photodiode array (PDA) detector (set at 220 and 280 nm wavelength) from ThermoFisher 
Scientific. Peptides were subjected to a 50-min linear gradient from 5% to 35% acetonitrile in 10 
mM ammonium bicarbonate pH 8 at a flow rate of 0.6 mL/min over an Agilent 300Extend C18 
column (3.5 μm particles, 4.6 mm ID and 220 mm in length). The peptide mixture was 
fractionated into a total of 96 fractions, which were consolidated into 24, from which 12 non-10 
adjacent samples were analyzed (Paulo et al. 2016). Samples were subsequently acidified with 
1% formic acid and vacuum centrifuged to near dryness. Each consolidated fraction was desalted 
via StageTip, dried again via vacuum centrifugation, and reconstituted in 5% acetonitrile, 5% 
formic acid for LC-MS/MS processing. Samples were analyzed using a Q Exactive mass 
spectrometer using the same instrument method and data processing as described above for yeast 15 
aggregate samples. 
 
Real-time RT-qPCR 
Cells were grown to exponential phase in SC medium containing 2% glucose as for 
aggregate purification. 5 OD600 units of culture were pelleted by centrifugation at 4°C (3000 rpm, 20 
2 min). The pellet was resuspended in 1 ml cold SC medium, transferred to a 2 ml microfuge 
tube and pelleted by centrifugation at 4°C (3000 rpm, 2 min). The pellet was flash-frozen in 
liquid nitrogen and stored at -80°C. To extract total RNA, ~200 μl of glass beads, 400 μl TES 
buffer (10 mM Tris pH 7.5, 10 mM EDTA, 0.5% SDS) and 400 μl acid phenol:chloroform (pH 
4.5) were added to the cell pellet and the tubes were vortexed for 30 minutes at 65°C. The phases 25 
were separated by centrifugation, and the top phase was transferred to a new tube containing 1 
ml of 120 mM sodium acetate in ethanol to precipitate RNA at 4°C. Precipitates were collected 
by centrifugation and resuspended in 100 μl DEPC-treated water. Total RNA was further 
purified using the RNeasy Mini kit (Qiagen), including DNase treatment, according to the 
manufacturer’s instructions. cDNA was synthesized from 750 ng total RNA using the 30 
SuperScript III First-Strand Synthesis SuperMix kit (Invitrogen) with random hexamer primers 
according to the manufacturer’s instructions. Real-time qPCR reactions were run using the 
SYBR Premix Ex Taq Perfect Real Time kit (TaKaRa Bio) and a Roche LightCycler 480 
(Roche) according to manufacturer’s instructions. qPCR primers are listed in Table S2. 
 35 
Turnover measurements for aggregated proteins 
 Protein turnover for aggregated proteins in disome II cells was determined by examining 
protein levels relative to WT before treatment with MG-132 and choloroquine, and 90 seconds 
and 300 seconds thereafter. Data were generated by Dephoure et al. (2014). 
  40 
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Orc protein half-life measurements 
 Cells were grown to exponential phase at 30°C in YEP medium containing 2% raffinose. 
Expression of HA tagged ORC2 and ORC5 was induced by diluting cultures into YEP medium 
containing 2% raffinose and 2% galactose for 20 minutes. The 0 minute time point was taken 
and protein synthesis was halted by the addition of 2% glucose and 0.5 mg/mL cycloheximide 5 
(Sigma-Aldrich). Time points were taken at the indicated times after the addition of glucose and 
cycloheximide. For each time point, approximately 0.5 OD600 units of culture were pelleted by 
centrifugation at 4°C (3000 rpm, 2 min). Cells were incubated at 4°C in 5% trichloroacetic acid 
for at least 10 minutes. Cell pellets were washed once with acetone and dried. Cells were lysed 
with glass beads in 100 μL of lysis buffer (50 mM Tris-Cl at pH 7.5, 1 mM EDTA, 2.75 mM 10 
dithiothreitol [DTT], complete protease inhibitor cocktail [Roche]) with a bead beater. Samples 
were boiled in 1X SDS loading buffer. Following SDS-PAGE and transfer of proteins to a 
nitrocellulose membrane, proteins were detected with the following antibodies. Pgk1 was 
detected using a mouse anti-Pgk1 antibody (Invitrogen) at a 1:10,000 dilution. Orc2-HA and 
Orc5-HA were detected using a mouse anti-HA antibody (HA.11 epitope, BioLegend). 15 
Quantification was performed using Fiji software (Schindelin et al. 2012). Protein levels were 
calculated by subtracting a background measurement for each band then dividing the intensity of 
the Orc band by the intensity of the Pgk1 band and normalizing all time points to the 0 minute 
time point. Half-life calculations were made by fitting curves to an exponential decay function in 
Prism (Graphpad).  20 
 
SILAC ms data normalization 
 To account for imperfect mixing of heavy and light-labeled cells, log2 ratios of proteins 
identified in aggregates were normalized by subtracting the average log2 ratio of all euploid 
encoded proteins in the total lysate obtained before pelleting aggregates for each experiment. 25 
 To control for non-biological batch effects between disomic cell-lines, each experiment 
was mean-centered to 0 by subtracting the mean of all SILAC ratios in that experiment from all 
data points. To return the normalized values to a baseline that more closely resembles the 
increase in protein aggregation in disomic strains observed in the raw data, a constant (log2 0.27) 
was added to all normalized data points. This constant is the mean log2 ratio of all euploid 30 
encoded proteins in the dataset prior to normalization.  
 
Cutoff determination for aggregation 
To decide what level of enrichment in disome aggregates constituted calling a protein 
aggregated, we used a 5% false discovery rate (FDR) obtained from the analysis of aggregates 35 
obtained from a WT(heavy)-WT(light) SILAC ms analysis. In this analysis, only 5% of 
identified proteins were enriched by greater than log2 1.27 in WT(heavy) aggregates. 
 
Signal to noise quantification of relative aggregate burden 
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 To account for the fact that some proteins are more abundant in aggregates than others, 
aggregate burden for each disome relative to WT was calculated by comparing the signal to 
noise ratio (S:N) of all heavy-labeled proteins to the S:N of all light-labeled proteins in protein 
aggregates. The sum of all light-labeled S:N was divided by the sum of all heavy-labeled S:N. 
This ratio was then normalized by dividing the ratio of light S:N to the heavy S:N for the total 5 
lysate. 
 
Gene Ontology (GO) analysis 
GO component analysis was performed using the Saccharomyces Genome Database 
(SGD) GO term finder (accessed 10/12/2018).  10 
 
Aggregate property calculations 
Disorder predictions for protein sequences were calculated using IUPRED on the ‘long’ 
setting. For each sequence, per-residue disorder scores were averaged across the full length of 
the protein. Grand average hydropathy (GRAVY) scores, isoelectric points, aliphatic indices, and 15 
aromaticity scores were calculated using the YeastMine tool on Saccharomyces Genome 
Database (SGD) (accessed 10/31/2018). 
 
Proteins not quantified due to low signal in WT channel 
In our mass spectrometry analysis pipeline, peptides for which either individual analysis 20 
channel had an intensity of less than 5 were discarded to avoid identifying proteins with an 
intensity of 0 in either the light or heavy channel; i.e. proteins found only in one condition or the 
other because a SILAC ratio cannot be calculated. We examined proteins that failed to pass the 
signal to noise threshold in one channel, but had a signal to noise ratio (S:N) of at least twice the 
threshold in the other channel. Using this method, we found 320 proteins that were quantified 25 
only in the disome channel compared to 72 quantified in only the WT channel (Supplemental 
Data S1). Importantly, 92 of the proteins quantified only in the disome channel were encoded by 
the duplicated chromosome as opposed to just 2 duplicated gene-encoded proteins quantified in 
only the WT channel. It is possible that proteins that are identified exclusively in the disome 
channel never aggregate in WT cells. It is also possible that with increased coverage these 30 
proteins would pass the signal threshold in both channels. To distinguish between these 
possibilities, we took advantage of a difference in coverage between two of our replicate 
experiments for disome II. In the low coverage experiment (366 proteins quantified), 9 proteins 
were not quantified due to low signal in the WT channel. In the high coverage experiment (847 
proteins quantified), we identified 6 of these proteins, and all 6 passed the detection threshold in 35 
both channels allowing us to calculate a SILAC ratio. 4 of these 6 proteins were considered 
aggregating using 2.4-fold [log2 of 1.27] as a cutoff. We conclude that proteins that cannot be 
quantified by SILAC ms due to low signal in WT cells are also likely enriched in aneuploid 
aggregates. 
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Heteromeric interface size determination 
 We searched for subunits of heteromeric protein complexes in the Protein Data Bank (on 
February 2, 2017) with >90% sequence identity to S. cerevisiae genes. We selected a single 
heteromeric structure for each gene – for genes with multiple structures available, we selected 
the structure with the greatest number of unique subunits in the complex, followed by the 5 
greatest number of atoms present in the polypeptide chain for ties. The total amount of 
heteromeric interface formed by each subunit was calculated using AREAIMOL (Winn et al. 
2011). 
 
Statistical analysis 10 
The statistical tests used are indicated in the Figure Legend, Materials and Methods, 
and/or in the Results section. Values of n, definition of center, error bars (e.g. SD and confidence 
intervals), and significance levels are reported in the Figures and/or in the Figure Legends. All 
box plots represent median and interquartile range (IQR) with whiskers indicating the 10-90 
percentile. All indicated statistical tests were performed using MATLAB or Prism. 15 
 
Data availability 
The mass spectrometry proteomics data have been deposited to the ProteomeXchange 
Consortium via the PRIDE (Vizcaíno et al. 2016) partner repository in seven parts with the 
following dataset identifiers: PXD011874, PXD011875, PXD011876, PXD011877, PXD011878, 20 
PXD011915, and PXD011916. 
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Figure 1. Identification of proteins that aggregate in aneuploid yeast cells. 
(A) Total lysate, aggregates and soluble fractions obtained from exponentially growing cells 
expressing Hsp104-eGFP (A31392) were analyzed for Hsp104 and Pgk1 abundance. 
(B) Protein aggregates and total lysates were prepared from euploid cells (WT, A35797), ndc10-
1 (ndc10-1, A13413) cells grown at 30°C for 4 hours, disome V cells (Dis V, A28265), and 5 
euploid (A2587) cells after an 8 minute heat shock at 42°C (heat shock). Total lysates and 
aggregate fractions were subjected to SDS-PAGE and stained with coomassie.  
(C) WT and disome cells were grown to exponential phase in SC medium containing heavy 
lysine and light lysine, respectively. Aggregated proteins are separated into two dot plots with 
red dots indicating proteins encoded on the duplicated chromosome and gray dots indicating 10 
proteins encoded on euploid chromosomes. The first column represents aggregates purified from 
a mixed sample of heavy lysine-labeled WT and light lysine-labeled WT. Lines represent mean 
and standard deviation. Upper dashed line at log2 1.27 shows the cut-off used to define 
aggregating proteins. ** p < 0.01, **** p < 0.0001; Mann-Whitney test. 
(D) The average aggregate enrichment of proteins encoded on euploid chromosomes that were 15 
identified in aggregates of at least 3/12 disomes. Only proteins with an average enrichment of 
>log2 1.27 as measured in Fig. 1C are shown. Error bars indicate standard deviation. 
(E) The enrichment of proteins from (D) was compared to their enrichment in aggregates 
purified from cells treated with radicicol (orange) or cells harboring the rpn6-1 allele (purple) 
from (Supplemental Fig. S4). * indicates proteins that were not quantified in either the radicicol 20 
or rpn6-1 experiments because they did not pass the detection threshold in aggregates purified 
from the reference strain but were readily detected in aggregates isolated from radicicol treated 
or rpn6-1 cells. 
(F) The percentage of proteins encoded by the duplicated chromosome that were enriched at a 
level greater than the aggregation threshold of log2 1.27 (black bars) and the percentage of 25 
proteins encoded by the duplicated chromosome as a fraction of the whole proteome (gray bars). 
n.s. not significant, **** p<0.0001; cumulative distribution function (CDF) for a hypergeometric 
distribution.  
(G) The percentage of proteins encoded by the duplicated chromosome that were not quantified 
by SILAC ms because the heavy-labeled (WT) peptides did not pass the detection threshold 30 
(black bars) and the percentage of proteins encoded by the duplicated chromosome as a fraction 
of the whole proteome (gray bars). n.s. not significant, ** p<0.01, *** p<0.001, **** p<0.0001; 
CDF for a hypergeometric distribution. 
Abbreviations: WT, wild-type; Dis, disome; avg, average. 
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Figure 2. Aggregate analysis in trisomic human cells. 
(A) RPE-1 cells and RPE-1 cells trisomic for either chromosome 12 or chromosome 21 were 
cultured in medium containing heavy lysine or light lysine, respectively, for 10 generations. 
Within each experiment, euploid encoded proteins (gray dots) were plotted separately from 
trisome encoded proteins (red dots). **** p<0.0001, n.s. not significant; Mann-Whitney test. 5 
(B, C) Enrichment of chromosome 12 (B) and 21 (C) encoded proteins in total aggregates (gray 
bars) and among the top 10% most highly enriched aggregated proteins (black bars). n.s. not 
significant, **** p<0.0001; cumulative distribution function (CDF) for a hypergeometric 
distribution.  
(D) Euploid and trisomy 21 cells were treated with 25nM chloroquine and 1µM MG-132 and 10 
aggregates were plotted as in (A). *** p<0.001; Mann-Whitney test. 
(E) Enrichment of chromosome 21 encoded proteins in total aggregates (gray bar) and among the 
top 10% most highly enriched aggregated proteins (black bar). **** p<0.0001; CDF for a 
hypergeometric distribution. 
Abbreviations: WT, wild-type; Ts, trisome; Chr, chromosome. 15 
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Figure 3. Stoichiometric imbalances of protein complex subunits cause protein aggregation. 
(A) The percentage of proteins encoded by duplicated chromosomes enriched by log2 1.27 or 
more in aggregates (red), the percentage of proteins encoded by euploid chromosomes enriched 
by a log2 1.27 or more in aggregates (gray), and the percentage of proteins in the genome (black) 
that are annotated to form protein complexes by Pu et al. (2009) was calculated. **** indicates 5 
p< 0.0001, n.s. not significant; cumulative distribution function (CDF) for a binomial 
distribution.  
(B) Diagram of eIF2 complex stoichiometry in disome V cells.  
(C) Gcd11-HA in aggregates and total lysates in WT, (A40189), disome V (A40190), disome V 
GCD11-HA/gcd11∆ (A40191), and WT URA3::GCD11-HA (WT +GCD11; A40192) cells. Only 10 
one of the two GCD11 genes in disome V cells was tagged with HA to ensure that protein levels 
are comparable between strains.  
(D) Quantification of Western blots in (C) (n=3; SD; *** indicates p<0.001, T test)  
(E) Cells were grown as in (C) and mRNA levels for eIF2 subunits was determined. Values were 
normalized to ACT1 then to WT expression levels (n=3; SD).  15 
(F-H) Western blot, relative aggregation quantification, and mRNA expression was determined 
for WT (A40193), disome V (A40194), and disome V pSUI2/SUI3 (A40195) cells as described 
in (C-E; n=3; SD; ** indicates p<0.01, T test) 
Abbreviations: WT, wild-type; Dis, disome; rel, relative.
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Figure 4. Excess proteins are either aggregated or degraded. 
(A, B) Correlation between enrichment in protein aggregates (measured in Fig. 1C) and relative 
protein levels (measured in disome lysates by Dephoure et al. (2014)) was determined for all 
proteins encoded by the duplicated chromosome quantified in both data sets (A), and duplicated 
subunits of protein complexes (B). Spearman correlation of 0.1810 (p=1.2x10-8) in (A) and 5 
0.2814 (p< 0.0001) in (B). Dashed lines indicate thresholds for proteins being considered 
aggregated (y-axes) or degraded (x-axes). The number of proteins that fall into each quadrant is 
indicated.  
(C, D) All duplicated proteins (C) and duplicated complex subunits (D) were separated into two 
bins: (1) aggregated proteins (red bars), which were defined as proteins with an enrichment of at 10 
least log2 1.27 in disomic aggregates; (2) non-aggregated proteins (gray bars) which were 
defined as proteins with an enrichment of log2 0.727 or less. Average relative levels in disome 
lysates as measured by Dephoure et al. (2014) are plotted. Error bars represent 95% confidence 
intervals. **** indicates p< 0.0001, Mann-Whitney test.  
Abbreviations: WT, wild-type; Dis, disome 15 
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Figure 5. Protein half-life determines whether a protein aggregates or is degraded. 
(A) Proteins encoded on duplicated chromosomes were separated into three categories: 
aggregated, degraded, and neither. Aggregated proteins (red), degraded proteins (blue) were 
defined as in Fig. 4A. Proteins that were identified in our analysis and that by Dephoure et al. 
(2014) but did not pass the threshold for aggregation or degradation were considered neither 5 
aggregated nor degraded (gray). The heteromeric interface sizes of the proteins in each category 
are plotted as box plots with whiskers representing the 10th-90th percentile. **** p< 0.0001, ** 
p< 0.01, n.s. not significant; Mann-Whitney test.  
(B) The change in levels of proteins encoded on chromosome II in disome II in total lysates of 
cells treated with 100 µM MG-132 and 10 mM chloroquine relative to WT (data from Dephoure 10 
et al. (2014)). Examples of aggregating proteins as determined in Fig. 1C and of degraded 
proteins as determined by Dephoure et al. (2014)) are shown. White bars indicate relative levels 
immediately before the addition of MG-132 and chloroquine, gray bars and black bars relative 
levels 90 seconds and 300 seconds thereafter, respectively.  
(C) Mean levels of all aggregating proteins as measured in (B) at each time point (error bars 15 
SEM; n.s. not significant; Wilcoxon matched-pairs signed rank test).  
(D) Disome II rpn6-1 (A40196) or WT (A23504) cells were grown to exponential phase at 30°C 
in SC medium containing light lysine and heavy lysine respectively and aggregating proteins 
were identified. Lines indicate mean and standard deviation. **** p < 0.0001, Mann-Whitney 
test. 20 
(E) Proteins considered degraded when duplicated by Dephoure et al. (2014) were examined in 
aggregates purified from disome II cells (Fig. 1C) and from disome II rpn6-1 cells (D). A protein 
was considered to aggregate when it was enriched by more than log2 1.27 in aggregates (red), 
not aggregated as enriched by less than log2 1.27 (gray). no ID indicates proteins that were not 
identified in aggregates (white). ** p < 0.01, cumulative distribution function for a binomial 25 
distribution. 
(F) Degree of aggregation was determined for all proteins in (E) in disome II aggregates and 
disome II rpn6-1 aggregates. Bars represent SD; ** p<0.01, Mann-Whitney test.  
(G, H) Relative protein levels as determined by Dephoure et al. (2014) (G) and relative 
aggregation as measured in Fig. 1C (H) for ORC subunits when encoded by disomic 30 
chromosomes (n.d. - not detected in aggregates). 
(I, J) Cells were grown to exponential phase at 30°C in YEP medium containing 2% raffinose. 
Expression of HA tagged ORC2 (A40197) and ORC5 (A40198) was induced with 2% galactose 
for 20 minutes. Then protein synthesis was halted by the addition of 2% glucose and 0.5 mg/mL 
cycloheximide (t=0). Protein levels were determined. Pgk1 was used as a loading control (I). 35 
Protein levels were quantified relative to the loading control and normalized to the 0 minute time 
point (J). 
Abbreviations: WT, wild-type; Dis, disome; MG, MG-132; CQ, chloroquine; sec, second; ln, 
natural logarithm; ID, identification; mins, minutes. 
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Figure 6. Dosage compensation by protein aggregation.  
(A, B) Total lysate and soluble fractions, obtained as described in Fig. 1A, were analyzed for 
disome II (A) and disome XII (B). Proteins encoded by euploid chromosomes (gray), proteins 
encoded by the duplicated chromosome (red). Data are represented as box plots with whiskers 
extending to 10th and 90th percentiles. Means are indicated below. Upper dashed line represents 5 
the theoretical mean for proteins encoded by the duplicated chromosome. **** p<0.0001; Mann-
Whitney test. 
(C) Changes in protein levels due to aggregation for proteins quantified in (A, B) were calculated 
for every protein by subtracting its log2 ratio in the soluble fraction from its log2 ratio in the total 
lysate. Disome II and disome XII data were pooled and separated into two subsets: euploid 10 
chromosome encoded proteins (gray) and disomic chromosome encoded proteins (red). 
Frequency distributions of each subset were then generated using a bin size of 0.1. Distributions 
were fit to Gaussian curves for euploid (dashed line) and disome (solid line). p-value shows that 
mean change of disome encoded proteins is significantly different from the mean change of 
euploid encoded proteins (Mann-Whitney test).  15 
(D) Changes in protein levels due to degradation for disome II and disome XII were calculated 
by subtracting the relative protein level from the relative mRNA level for each gene as measured 
by Dephoure et al. (2014). Frequency distributions were generated and curve fitting was 
performed on the pooled data as in (C). p-value shows that mean change of disome encoded 
proteins is significantly different from the mean change of euploid encoded proteins (Mann-20 
Whitney test).  
(E) The percentage of proteins encoded by the duplicated chromosome that decreased in levels 
by at least a log2 of 0.2, 0.4, 0.6, and 0.8 due to aggregation (red bars) was calculated using the 
data described in (C) and due to degradation (blue bars) using the data in (D). **** p<0.0001, ** 
p<0.01, * p<0.05; Chi-squared test. 25 
(F) Correlation between protein levels in total lysate and reduction in levels due to aggregation 
was determined for proteins encoded on duplicated chromosomes from the pooled data set of 
disome II (A) and disome XII (B). Spearman correlation of 0.3589 (p< 0.0001). Dashed lines 
indicate thresholds for proteins being considered dosage compensated by aggregation (y-axes) or 
degradation (x-axes). The number of proteins that fall into each quadrant is indicated (note: 19 30 
data points fell outside the range of the axes but were included in the calculations).  
(G) Proteins encoded on duplicated chromosomes were separated into two categories: dosage 
compensated proteins (red) were defined as their levels being reduced by at least log2 0.4 in the 
soluble fraction relative to the total lysate. Not dosage compensated proteins (gray) were defined 
as their levels being reduced by less than log2 0.4. Mean levels in total lysates are plotted; error 35 
bars indicate 95% confidence intervals. **** p<0.0001; Mann-Whitney test.  
Abbreviations: WT, wild-type; Dis, disome. 
